Fludara (Oral) Phase II Study for Indolent Lymphoma
Clinical trial NCT00688883 · COMPLETED
Trial details
- NCT number
- NCT00688883
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Primary completion
- 2004-08-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.